Chronic insomnia, by far the most commonly encountered sleep disorder in medical practice, is characterized by difficulty falling or staying asleep at night and increased fatigue during the day. Interleukin-6 (IL-6) and tumor necrosis factor (TNF) are fatigue-inducing cytokines, and the daytime secretion of IL-6 is negatively influenced by the quantity and quality of the previous night's sleep. We hypothesize that the poor quality of insomniacs' sleep is associated with a hypersecretion of these 2 cytokines during the daytime, which, in turn, correlates with the fatigue experienced by these patients. Eleven young insomniacs (6 men and 5 women) and 11 (8 men and 3 women) age- and body mass index (BMI)-matched healthy controls participated in the study. Subjects were recorded in the sleep laboratory for 4 consecutive nights and serial 24-hour plasma measures of IL-6 and TNF were obtained during the 4th day. Insomniacs compared to controls slept poorly (sleep latency and wake were increased, whereas percentage sleep time was decreased during baseline nights, all P <.05). The mean 24-hour IL-6 and TNF secretions were not different between insomniacs and controls. However, the difference in the change (increase) of IL-6 plasma levels from midafternoon (2 PM) to evening (9 PM) between insomniacs and controls was significant (P <.01). Furthermore, cosinor analysis showed a significant shift of the major peak of IL-6 secretion from nighttime (4 AM) to evening (7 PM) in insomniacs compared to controls (P <.05). Also, while TNF secretion in controls showed a distinct circadian rhythm with a peak close and prior to the offset of sleep (P <.05), such a rhythm was not present in insomniacs. Finally, daytime secretion of TNF in insomniacs was characterized by a regular rhythm of 4 hours (P <.05); such a distinct periodicity was not present in controls. We conclude that chronic insomnia is associated with a shift of IL-6 and TNF secretion from nighttime to daytime, which may explain the daytime fatigue and performance decrements associated with this disorder. The daytime shift of IL-6 and TNF secretion, combined with a 24-hour hypersecretion of cortisol, an arousal hormone, may explain the insomniacs' daytime fatigue and difficulty falling asleep.

Download full-text PDF

Source
http://dx.doi.org/10.1053/meta.2002.33357DOI Listing

Publication Analysis

Top Keywords

chronic insomnia
8
tumor necrosis
8
necrosis factor
8
cytokines daytime
8
men women
8
sleep
6
insomnia associated
4
associated shift
4
shift interleukin-6
4
interleukin-6 tumor
4

Similar Publications

Background: People share health-related experiences and treatments, such as for insomnia, in digital communities. Natural language processing tools can be leveraged to understand the terms used in digital spaces to discuss insomnia and insomnia treatments.

Objective: The aim of this study is to summarize and chart trends of insomnia treatment terms on a digital insomnia message board.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Ageing Epidemiology Reseach Unit (AGE), School of Public Health, Imperial College London, London, UK.

Background: Several studies have investigated the link between sleep disturbances and allostatic load (AL), but the results are varied, and less is known about the associations in clinical samples. The goal of this study is to assess the associations between sleep disturbances and AL among memory clinic participants, and to examine differences according to sex, beta-amyloid status and history of burnout status.

Method: The study was based on 146 memory clinic participants diagnosed with either Mild Cognitive Impairment (MCI) or Subjective Cognitive Impairment (SCI) in the Cortisol and Stress in Alzheimer's Disease Study (Co-STAR) (Sweden).

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Background: Timely identification of mild cognitive impairment (MCI) is key to early intervention. While primary care providers are the most likely entry point to detect early signs of MCI, their detection rates are low. Building upon a published study, we used electronic health records (EHR) to develop a clinically enhanced MCI risk prediction algorithm.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Taipei Medical University, Taipei City, Taiwan, Taiwan.

Background: As global populations age, dementia prevalence is increasing, with projections suggesting significant growth in the number of affected individuals and their caregivers. In Taiwan, family caregivers provide substantial support, often facing intense burdens due to prolonged caregiving duties. This study aims to assess the psychological health of these caregivers to better understand and address their needs.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Finnish Institute for Health and Welfare, Helsinki, Uusimaa, Finland.

Background: Sleep disturbances have been suggested as potential risk factors for neurodegenerative diseases. However, longitudinal studies on insomnia and dementia have mostly had too short follow-up time to separate etiological risk factors from prodromal symptoms. Moreover, the impact of mortality as a competing risk has been overlooked.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!